أوزمبيك: أدوية تقلل من انتشار سرطان الثدي
A new study published this week in JAMA Oncology suggests that GLP-1 receptor agonists—a class of weight-loss drugs including semaglutide (Ozempic) and tirzepatide (Mounjaro)—may significantly reduce cancer progression risk in ... Read More